Insider Selling: Doximity (NYSE:DOCS) Director Sells $49,900.00 in Stock

Posted by Francis Steltz on Aug 30th, 2026

Doximity, Inc. (NYSE:DOCS – Get Free Report) Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $24.95, for a total transaction of $49,900.00. Following the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $494,983.05. This trade represents a 9.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Doximity Stock Up 4.5%

DOCS stock opened at $26.74 on Friday. The firm has a market cap of $4.77 billion, a price-to-earnings ratio of 31.46, a PEG ratio of 20.91 and a beta of 1.29. The company’s fifty day simple moving average is $22.71 and its 200 day simple moving average is $23.08. Doximity, Inc. has a 12-month low of $17.15 and a 12-month high of $76.51.

Doximity (NYSE:DOCS – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.13. The firm had revenue of $156.62 million during the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The business’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.36 earnings per share. Research analysts expect that Doximity, Inc. will post 0.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on DOCS. Leerink Partners reduced their price objective on shares of Doximity from $31.00 to $25.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. BTIG Research downgraded shares of Doximity from a “buy” rating to a “neutral” rating in a research report on Thursday, May 14th. Wolfe Research raised shares of Doximity to an “outperform” rating in a research note on Thursday, August 13th. Jefferies Financial Group cut shares of Doximity from a “buy” rating to a “hold” rating and cut their price objective for the stock from $51.00 to $19.00 in a research report on Thursday, May 14th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $41.00 target price on shares of Doximity in a research report on Friday, August 7th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $32.43.

View Our Latest Analysis on DOCS

Hedge Funds Weigh In On Doximity

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Doximity by 4.1% during the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock valued at $588,281,000 after purchasing an additional 518,916 shares during the period. Carmignac Gestion grew its holdings in Doximity by 127.8% during the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock valued at $100,480,000 after buying an additional 2,418,971 shares in the last quarter. UBS Group AG increased its position in shares of Doximity by 26.5% during the fourth quarter. UBS Group AG now owns 680,260 shares of the company’s stock valued at $30,122,000 after buying an additional 142,408 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Doximity by 325,436.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock worth $57,515,000 after buying an additional 1,298,492 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in shares of Doximity by 28.4% in the first quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock valued at $4,806,000 after acquiring an additional 45,618 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.